eprintid: 100047
rev_number: 3
eprint_status: archive
dir: disk0/00/10/00/47
datestamp: 2026-06-19 08:00:43
lastmod: 2026-06-19 08:00:43
status_changed: 2026-06-19 08:00:43
type: article
metadata_visibility: show
creators_name: G`opirjonova D.D, G`opirjonova D.D
creators_name: Alyavi A.L, Alyavi A.L
title: YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA  INTERLEYKIN-6 AHAMIYATI
ispublished: pub
keywords: Yurak ishemik kasalligi, biomarkerlar, yallig`lanish, interleykin-6
abstract: Yallig`lanish bu yurak ishemik kasalligida (YuIK) ishtirok etuvchi muhim jarayon hisoblanadi. Metabolik stress, gemodinamik ortiqcha yuk va endoteliy va miyokard hujayralarida neyrogumaral giperaktivatsiyaga javoban interleykin (IL) 1 va 6 kabi yallig`lanishga qarshi sitokinlar chiqariladi. Dastlab, bu jarayon organizimni stresga moslashishini taminlaydi, ammo keyinchlik kasallik davrida ular endothelial va yurak disfunktsiyasi orqali miyokard fibroziga olib keladigan zararli ta`sirlarni keltirib chiqaradi. Tadqiqotlar shuni ko`rsatadiki yurak ishemik kasalligida bemorlarda interleykin(IL)6 yallig`lanish mediatori ko`payib ketadi.
date: 2024-05-15
official_url: https://universalpublishings.com/index.php/cusr/article/view/5719
full_text_status: public
publication: "Conference on Universal Science Research 2023"
volume: 2
number: 5
pagerange: 92-95
citation:   G`opirjonova D.D, G`opirjonova D.D, Alyavi A.L, Alyavi A.L  (2024) YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA INTERLEYKIN-6 AHAMIYATI.  "Conference on Universal Science Research 2023", 2 (5).  pp. 92-95.      
document_url: https://arxiv.universalpublishings.com/id/eprint/100047/1/92-95_G_opirjonova_D_KONFERENSIYA_CUSR.pdf